Published in Adv Cancer Res on January 01, 2008
Mesenchymal stromal cells: current understanding and clinical status. Stem Cells (2010) 4.79
Direct conversion of C. elegans germ cells into specific neuron types. Science (2010) 3.31
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol (2011) 3.05
The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell (2009) 2.72
Stem cell paracrine actions and tissue regeneration. Regen Med (2010) 1.99
Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation (2010) 1.67
Induced pluripotency and oncogenic transformation are related processes. Stem Cells Dev (2012) 1.64
Lessons from human teratomas to guide development of safe stem cell therapies. Nat Biotechnol (2012) 1.43
Mesenchymal stem cell pretreatment of non-heart-beating-donors in experimental lung transplantation. J Cardiothorac Surg (2014) 1.40
The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol (2009) 1.39
Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol (2012) 1.31
Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell (2009) 1.26
Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci U S A (2013) 1.22
Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen Med (2011) 1.21
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle (2013) 1.20
Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging. J R Soc Interface (2010) 1.16
Tumor-initiating and -propagating cells: cells that we would like to identify and control. Neoplasia (2010) 1.11
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency. Sci Rep (2012) 1.11
Standardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progeny. PLoS One (2012) 1.10
Design and development of tissue engineered lung: Progress and challenges. Organogenesis (2009) 1.10
Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway. Cell Cycle (2013) 1.08
Derivation of 30 human embryonic stem cell lines--improving the quality. In Vitro Cell Dev Biol Anim (2010) 1.07
The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. Cell Cycle (2012) 1.04
Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? Crit Care (2012) 1.04
Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Rep (2014) 1.04
Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One (2009) 1.02
Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. Stem Cells Transl Med (2015) 1.02
Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules. Biol Direct (2009) 0.98
Stem cells as therapeutic vehicles for the treatment of high-grade gliomas. Neuro Oncol (2011) 0.96
Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin). Cell Cycle (2012) 0.95
A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS One (2010) 0.95
Human fetal and adult bone marrow-derived mesenchymal stem cells use different signaling pathways for the initiation of chondrogenesis. Stem Cells Dev (2013) 0.95
Development of an inducible caspase-9 safety switch for pluripotent stem cell-based therapies. Mol Ther Methods Clin Dev (2014) 0.94
Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet? Mol Ther (2011) 0.94
Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells. Semin Immunopathol (2011) 0.94
Use of Encapsulated Stem Cells to Overcome the Bottleneck of Cell Availability for Cell Therapy Approaches. Transfus Med Hemother (2010) 0.94
Effects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests. Front Cell Neurosci (2014) 0.94
Key developments in stem cell therapy in cardiology. Regen Med (2012) 0.92
Development of pluripotent stem cells for vascular therapy. Vascul Pharmacol (2012) 0.90
Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. Obstet Gynecol (2009) 0.90
The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke. Front Neurol (2015) 0.89
Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease. Vasc Med (2012) 0.89
Regenerative chemical biology: current challenges and future potential. Chem Biol (2011) 0.88
Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit Rev Biomed Eng (2011) 0.88
Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability. Front Cell Neurosci (2014) 0.88
Assay validation for the assessment of adipogenesis of multipotential stromal cells--a direct comparison of four different methods. Cytotherapy (2013) 0.87
Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. Stem Cells Int (2011) 0.86
Regenerative therapy for neuronal diseases with transplantation of somatic stem cells. World J Stem Cells (2013) 0.86
Stability of genomic imprinting in human induced pluripotent stem cells. BMC Genet (2013) 0.85
Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs. J Immunol (2015) 0.85
Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells. PLoS One (2013) 0.85
Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells. Stem Cell Res Ther (2012) 0.85
A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI). BMJ Open (2014) 0.84
There is more to a lipid than just being a fat: sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells. Neurochem Res (2010) 0.84
Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice. Cell Death Dis (2014) 0.83
Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools. Biomed Res Int (2014) 0.83
Stem cells for reprogramming: could hUMSCs be a better choice? Cytotechnology (2012) 0.82
The new generation of beta-cells: replication, stem cell differentiation, and the role of small molecules. Rev Diabet Stud (2010) 0.82
What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? BMC Neurol (2011) 0.81
Empowering Adult Stem Cells for Myocardial Regeneration V2.0: Success in Small Steps. Circ Res (2016) 0.81
Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev (2014) 0.81
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities. Stem Cells Cloning (2010) 0.81
Graphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage. Sci Rep (2016) 0.81
Interwoven four-compartment capillary membrane technology for three-dimensional perfusion with decentralized mass exchange to scale up embryonic stem cell culture. Cells Tissues Organs (2010) 0.81
Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage. Curr Neuropharmacol (2016) 0.81
All-trans retinoic acid promotes smooth muscle cell differentiation of rabbit bone marrow-derived mesenchymal stem cells. J Zhejiang Univ Sci B (2010) 0.80
Stem cell approaches for the treatment of type 1 diabetes mellitus. Transl Res (2010) 0.80
Stem cell technology for tendon regeneration: current status, challenges, and future research directions. Stem Cells Cloning (2015) 0.80
Regenerative medicine and the gut. Gastroenterology (2011) 0.80
Perspectives on the use of stem cells for autism treatment. Stem Cells Int (2013) 0.80
Ceramide and sphingosine-1-phosphate signaling in embryonic stem cell differentiation. Methods Mol Biol (2012) 0.79
A novel xenogeneic co-culture system to examine neuronal differentiation capability of various adult human stem cells. PLoS One (2011) 0.79
Early events in xenograft development from the human embryonic stem cell line HS181--resemblance with an initial multiple epiblast formation. PLoS One (2011) 0.79
Neural stem cell progeny regulate stem cell death in a Notch and Hox dependent manner. Cell Death Differ (2015) 0.79
Stem cell-based approach for the treatment of Parkinson's disease. Med J Islam Repub Iran (2015) 0.79
Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine. Stem Cells Transl Med (2015) 0.78
Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells. Neural Regen Res (2013) 0.78
Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats. Stem Cells Transl Med (2014) 0.78
Stem cell therapy in intracerebral hemorrhage rat model. World J Stem Cells (2015) 0.78
Plasticity of male germline stem cells and their applications in reproductive and regenerative medicine. Asian J Androl (2015) 0.77
Priming the Surface of Orthopedic Implants for Osteoblast Attachment in Bone Tissue Engineering. Int J Med Sci (2015) 0.77
PI3K/AKT Signaling Pathway Is Essential for Survival of Induced Pluripotent Stem Cells. PLoS One (2016) 0.76
Neural stem cells respond to stress hormones: distinguishing beneficial from detrimental stress. Front Physiol (2015) 0.76
Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations. Stem Cells Cloning (2009) 0.76
Quo Vadis medycyno regeneracyjna?: Quo Vadis Regenerative Medicine? Acta Haematol Pol (2013) 0.76
EIF2S3Y suppresses the pluripotency state and promotes the proliferation of mouse embryonic stem cells. Oncotarget (2016) 0.76
Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat. Behav Neurol (2016) 0.75
STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation. Oncotarget (2016) 0.75
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. Int J Mol Sci (2016) 0.75
Induction of Neural Progenitor-Like Cells from Human Fibroblasts via a Genetic Material-Free Approach. PLoS One (2015) 0.75
Stem cell therapy for chronic heart failure: an updated appraisal. Expert Opin Biol Ther (2013) 0.75
Gene and cell therapies for the failing heart to prevent sudden arrhythmic death. Minerva Cardioangiol (2012) 0.75
Co-Registration of Bioluminescence Tomography, Computed Tomography, and Magnetic Resonance Imaging for Multimodal In Vivo Stem Cell Tracking. Tomography (2016) 0.75
Transdifferentiation of Fibroblasts by Defined Factors. Cell Reprogram (2015) 0.75
Successful transplantation of motoneurons into the peripheral nerve depends on the number of transplanted cells. Nagoya J Med Sci (2015) 0.75
Potential uses of cord blood in cardiac surgery. J Blood Transfus (2012) 0.75
Research Advancements in Porcine Derived Mesenchymal Stem Cells. Curr Stem Cell Res Ther (2016) 0.75
Stem cell translation and bioethics. Ann Neurosci (2012) 0.75
miR-302 regulates pluripotency, teratoma formation and differentiation in stem cells via an AKT1/OCT4-dependent manner. Cell Death Dis (2016) 0.75
Human stem cells for craniomaxillofacial reconstruction. Stem Cells Dev (2014) 0.75
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol (2011) 3.97
Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol (2009) 3.96
Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell (2011) 3.73
The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer (2011) 3.42
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell (2007) 2.87
Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell (2011) 2.71
Ethics. The ISSCR guidelines for human embryonic stem cell research. Science (2007) 2.62
Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 2.53
Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development (2006) 2.27
Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (2005) 2.24
Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells (2004) 2.07
Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell (2013) 2.02
Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells (2009) 1.98
Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells (2003) 1.75
Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim (2010) 1.70
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation (2004) 1.53
Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Hum Reprod (2004) 1.49
Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Res (2004) 1.39
The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol (2009) 1.39
Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells (2008) 1.38
Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells (2009) 1.30
Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res (2010) 1.27
Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol (2014) 1.27
The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol (2004) 1.25
The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle (2009) 1.17
Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells (2010) 1.15
Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nat Commun (2013) 1.12
Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells (2008) 1.11
Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nat Protoc (2013) 1.11
Expanding the boundaries of embryonic stem cells. Cell Stem Cell (2012) 1.06
The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nat Biotechnol (2005) 1.06
Human embryonic stem cells as a cellular model for human disorders. Mol Cell Endocrinol (2006) 1.05
Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party. Stem Cell Rev (2011) 1.02
Genomic stability in reprogramming. Curr Opin Genet Dev (2012) 1.02
Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One (2009) 1.02
A molecular view on pluripotent stem cells. FEBS Lett (2002) 1.02
High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells (2012) 1.01
Study of hepatocyte differentiation using embryonic stem cells. J Cell Biochem (2005) 1.01
Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells (2007) 1.00
Integration and differentiation of human embryonic stem cells transplanted to the chick embryo. Dev Dyn (2002) 0.99
Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. Stem Cells (2006) 0.98
Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. J Mol Cell Biol (2012) 0.96
Human embryonic stem cells as a model for early human development. Best Pract Res Clin Obstet Gynaecol (2004) 0.95
Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle (2010) 0.95
Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells. Nat Struct Mol Biol (2011) 0.95
The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells (2006) 0.94
Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells. Stem Cell Reports (2013) 0.94
Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell (2010) 0.92
Human embryonic stem cells: the battle between self-renewal and differentiation. Regen Med (2006) 0.88
Molecular and functional characterizations of gastrula organizer cells derived from human embryonic stem cells. Stem Cells (2011) 0.87
Characterization of gastrulation-stage progenitor cells and their inhibitory crosstalk in human embryoid bodies. Stem Cells (2010) 0.86
Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In Vitro Cell Dev Biol Anim (2010) 0.86
Factors controlling human embryonic stem cell differentiation. Methods Enzymol (2003) 0.85
Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. J Cell Mol Med (2010) 0.83
Cell lines derived from human parthenogenetic embryos can display aberrant centriole distribution and altered expression levels of mitotic spindle check-point transcripts. Stem Cell Rev (2009) 0.83
A computerized database-scan to identify c-MYC targets. Gene (2002) 0.82
Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells. Stem Cells (2012) 0.81
Involvement of parental imprinting in the antisense regulation of onco-miR-372-373. Nat Commun (2013) 0.81
Targeting pancreatic progenitor cells in human embryonic stem cell differentiation for the identification of novel cell surface markers. Stem Cell Rev (2012) 0.80
The "brainy side" of human embryonic stem cells. J Neurosci Res (2004) 0.80
New balance in pluripotency: reprogramming with lineage specifiers. Cell (2013) 0.80
The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem Cell Res (2012) 0.79
Human pluripotent stem cells with distinct X inactivation status show molecular and cellular differences controlled by the X-Linked ELK-1 gene. Cell Rep (2013) 0.79
Aneuploid human embryonic stem cells: origins and potential for modeling chromosomal disorders. Regen Med (2011) 0.78
Manipulation of the human genome in human embryonic stem cells. Stem Cell Rev (2005) 0.77
New ISSCR guidelines: clinical translation of stem cell research. Lancet (2016) 0.77
Differentiation and genetic manipulation of human embryonic stem cells and the analysis of the cardiovascular system. Trends Cardiovasc Med (2003) 0.76
Stepwise differentiation of human embryonic stem cells into early endoderm derivatives and their molecular characterization. Stem Cell Res (2011) 0.76
Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha. Stem Cells (2015) 0.76
DUXO, a novel double homeobox transcription factor, is a regulator of the gastrula organizer in human embryonic stem cells. Stem Cell Res (2012) 0.76
Corrigendum: Hallmarks of pluripotency. Nature (2015) 0.75
Epigenetic mechanism of FMR1 inactivation in Fragile X syndrome. Int J Dev Biol (2017) 0.75
Human ES cell lines--introduction. In Vitro Cell Dev Biol Anim (2010) 0.75